These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 115527)

  • 1. [Short term chemotherapy of tuberculosis. Current experimental findings in short term chemotherapy].
    Grosset J
    Bull Int Union Tuberc; 1978 Dec; 53(4):281-3. PubMed ID: 115527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Short-term chemotherapy of tuberculosis in Chile. Bacteriological considerations].
    Valenzuela P
    Rev Med Chil; 1983 Jul; 111(7):747-9. PubMed ID: 6440255
    [No Abstract]   [Full Text] [Related]  

  • 3. [Short term chemotherapy of tuberculosis. Bactericidal mechanisms in short term chemotherapy].
    Mitchison DA; Dickinson JM
    Bull Int Union Tuberc; 1978 Dec; 53(4):270-5. PubMed ID: 115526
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental basis for the chemotherapy of tuberculosis.
    Grumbach F
    Antimicrob Agents Chemother (Bethesda); 1965; 5():1058-64. PubMed ID: 4956791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Response to the short-course chemotherapy in patients presenting initial resistance].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Influence of background factors, factors regarding the method of treatment and the course of the disease on the emergence of drug resistance].
    Yamamoto M; Nakamura H; Inagaki H
    Kekkaku; 1970 Oct; 45(10):349-57. PubMed ID: 4991618
    [No Abstract]   [Full Text] [Related]  

  • 8. Short course chemotherapy in childhood tuberculosis.
    Chopra K
    Indian Pediatr; 1995 Jun; 32(6):625-8. PubMed ID: 8613329
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and epidemiological aspects of controlled short-term chemotherapy].
    Khomenko AG
    Probl Tuberk; 1998; (4):16-20. PubMed ID: 9771030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitubercular properties of some derivatives of pyrazine carboxylic acid].
    Solov'ev VN; Pavolo EP
    Farmakol Toksikol; 1967; 30(6):734-7. PubMed ID: 4970686
    [No Abstract]   [Full Text] [Related]  

  • 11. Preclinical testing of new drugs for tuberculosis: current challenges.
    Lenaerts AJ; Degroote MA; Orme IM
    Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial effectiveness of long-acting isoniazid in the experiment].
    Shkurupií VA; Kurunov IN; Arkhipov SA
    Probl Tuberk; 1997; (2):54-6. PubMed ID: 9235596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to a formal theory of the dosage regimen calculation in intermittent chemotherapy of tuberculosis.
    Bercea O; Bonciocat N
    Arzneimittelforschung; 1970 Feb; 20(2):241-5. PubMed ID: 4986038
    [No Abstract]   [Full Text] [Related]  

  • 14. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2006 Aug; 261(2):181-6. PubMed ID: 16907718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antituberculous activities of the tuberactinomycins in vitro and in experimental animals].
    Koseki Y; Okamoto S; Muroashi T
    Kekkaku; 1973 May; 48(5):189-96. PubMed ID: 4200134
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of thiocarbonylides (isoxyl and ethoxide) under experimental and clinical conditions].
    Shmelev NA; Kozulitsyna TI; Utkin VV; Poleshchuk AK; Stepanian ES
    Probl Tuberk; 1966; 44(6):13-23. PubMed ID: 4968672
    [No Abstract]   [Full Text] [Related]  

  • 17. Fighting tuberculosis: old drugs, new formulations.
    Blasi P; Schoubben A; Giovagnoli S; Rossi C; Ricci M
    Expert Opin Drug Deliv; 2009 Sep; 6(9):977-93. PubMed ID: 19678791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
    Rist N
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):295-6. PubMed ID: 5004388
    [No Abstract]   [Full Text] [Related]  

  • 19. [Short term chemotherapy of tuberculosis. Current status of short term chemotherapy].
    Fox W
    Bull Int Union Tuberc; 1978 Dec; 53(4):284-98. PubMed ID: 756304
    [No Abstract]   [Full Text] [Related]  

  • 20. DOTS in Haiti.
    Ollé-Goig JE
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):282-3. PubMed ID: 10751080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.